SEOUL, South Korea--(BUSINESS WIRE)--Feb 9, 2026--
Galux, a South Korea-based biotech pioneering AI-driven protein therapeutics design, today announced the successful completion of a $29 million (KRW 42 billion) Series B financing. With this round, the company’s total capital raised reaches $47 million (KRW 68 billion).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209145576/en/
The Series B round brought together a group of long-term supporters and new institutional backers. InterVest, DAYLI Partners, and PATHWAY Investment participated as existing investors, alongside new investors including Yuanta Investment, Korea Development Bank (KDB), SL Investment, NCORE Ventures, SneakPeek Investments, Korea Investment & Securities, and Mirae Asset Securities.
Galux previously closed an $18 million (KRW 21 billion) Series A financing in 2022, which enabled the company to advance its AI platform and R&D capabilities. Since then, the company has delivered key R&D and business milestones, successfully closing its Series B and reinforcing its execution and growth momentum.
“Since our initial seed investment, Galux has consistently demonstrated strong technical depth and disciplined execution,” said Sang-gyun Kim, Ph.D, Executive Managing Director at InterVest. “The company’s capability to build a globally competitive AI platform for de novo protein design strengthens our conviction in its technology and its long-term potential to transform drug discovery.”
Galux has developed an AI-driven protein design platform, GaluxDesign, which specializes in de novo antibody design, one of the most technically challenging areas in the field. GaluxDesign successfully generated high-affinity antibodies against a range of therapeutic targets and confirmed that its AI-designed antibody structure was highly consistent with the cryo-EM experimental structure, demonstrating both the precision and generalizability of the platform.
The tight integration of pioneering AI with efficient experimental feedback from the company’s internal wet lab is rapidly enhancing the platform’s precision and reliability. Building on this foundation, the platform is being extended to increasingly challenging target classes, including GPCRs and ion channels.
Leveraging its technological strengths, Galux continues to expand its strategic partnerships. The company has established co-development partnerships with major domestic pharmaceutical companies such as Celltrion and LG Chem, and recently announced a collaboration with Boehringer Ingelheim, marking an important step in its global growth.
Proceeds from this financing round will be used to further enhance its AI platform, expand R&D infrastructure, and accelerate preclinical validation of proprietary pipelines. Through these efforts, Galux aims to unlock new therapeutic opportunities and expand drug discovery into target classes that have historically been difficult to address using conventional approaches.
“Rapidly evolving AI technologies are driving a paradigm shift in drug discovery—from empirical discovery to rational drug design,” said Cha-ok Seok, CEO of Galux. “This funding will accelerate the development of next-generation AI that goes beyond binder design to incorporate functional activity and developability, enabling the creation of more robust and therapeutically viable molecules.”
About Galux
Galux is redefining the future of drug discovery through protein design AI. The company combines deep-learning with the physical principles of protein folding and interaction to create therapeutic proteins from scratch, enabling precise and tailored design of therapeutic molecule across a broad range of targets and modalities. With pioneering technology and growing global partnerships, Galux is advancing a new paradigm of rational, AI-powered drug discovery. For more information, visit galux.co.kr.
Galux announced a $29 million Series B round—bringing total funding to $47 million—to accelerate its AI-driven protein therapeutics platform and growth.
The Latest
President Donald Trump has lashed out at reporters raising questions about the Epstein files, demanding that the country “get onto something else,” but that’s highly unlikely. Many of the documents haven’t been released, and the ones now public were heavily redacted.
The Department of Justice will allow members of Congress to review unredacted files on the convicted sex offender Jeffrey Epstein starting on Monday, according to a letter that was sent to lawmakers. The letter obtained by The Associated Press says that lawmakers will be able to review unredacted versions of the more than 3 million files that the Justice Department has released to comply with a law passed by Congress last year.
While investigators collected ample proof that Epstein sexually abused underage girls, they found scant evidence the well-connected financier led a sex trafficking ring serving powerful men, an Associated Press review of internal Justice Department records shows.
Meanwhile, Trump said he won't apologize for a racist social media post featuring former President Barack Obama and his wife, Michelle Obama. The White House ultimately blamed the post on a staffer and Trump said “I didn’t make a mistake.”
And Dr. Mehmet Oz is urging people to get inoculated against the measles at a time of outbreaks across several states and as the United States is at risk of losing its measles elimination status. “Take the vaccine, please,” said Oz, “We have a solution for our problem.”
The Latest:
In a social media post Sunday night, the president said the Grammy-winning top-streaming megastar Bad Bunny “doesn’t represent our standards of Success, Creativity, or Excellence. Nobody understands a word this guy is saying, and the dancing is disgusting.”
Bad Bunny performed nearly entirely in Spanish, recreating his native Puerto Rico from sugar cane fields to a raucous wedding featuring Lady Gaga. And in a country where masked ICE agents are pulling people from their homes and neighborhoods, his patriotism was political:
He carried a football with “Together we are America,” written on the pigskin, and he wrapped up by leading a phalanx of dancers carrying the flags of many Latin American nations and Canada along with the Stars and Stripes, shouting “God Bless America — All of America!”
Behind him, a screen read “The only thing more powerful than hate is love,” repeating comments he made at the 2026 Grammys.
▶ Read more
The FBI pored over Jeffrey Epstein’s bank records and emails. It searched his homes. It spent years interviewing his victims and examining his connections to some of the world’s most influential people.
But while investigators collected ample proof that Epstein sexually abused underage girls, they found scant evidence the well-connected financier led a sex trafficking ring serving powerful men, an Associated Press review of internal Justice Department records shows.
Videos and photos seized from Epstein’s homes in New York, Florida and the Virgin Islands didn’t depict victims being abused or implicate anyone else in his crimes, a prosecutor wrote in one 2025 memo.
An examination of Epstein’s financial records, including payments he made to entities linked to influential figures in academia, finance and global diplomacy, found no connection to criminal activity, said another internal memo in 2019.
While one Epstein victim made highly public claims that he “lent her” to his rich friends, agents couldn’t confirm that and found no other victims telling a similar story, the records said.
▶ Read more
Beyond the car windows being smashed, people tackled on city streets — or even a little child with a floppy bunny ears snowcap detained — the images of masked federal officers has become a flashpoint in the Trump administration’s immigration enforcement operations.
Not in recent U.S. memory has an American policing operation so consistently masked its thousands of officers from the public, a development that the Department of Homeland Security believes is important to safeguard employees from online harassment. But experts warn masking serves another purpose, inciting fear in communities, and risks shattering norms, accountability and trust between the police and its citizenry.
Whether to ban the masks — or allow the masking to continue — has emerged as a central question in the debate in Congress over funding Homeland Security ahead of Friday’s midnight deadline, when it faces a partial agency shutdown.
▶ Read more
Centers for Medicare & Medicaid Services administrator Dr. Mehmet Oz listens as President Donald Trump speaks about TrumpRx in the South Court Auditorium in the Old Eisenhower Executive Office Building on the White House campus, Thursday, Feb. 5, 2026, in Washington. (AP Photo/Alex Brandon)
A leading U.S. health official on Sunday urged people to get inoculated against the measles at a time of outbreaks across several states and as the United States is at risk of losing its measles elimination status.
“Take the vaccine, please,” said Dr. Mehmet Oz, the Centers for Medicare and Medicaid Services administrator whose boss has raised suspicion about the safety and importance of vaccines. “We have a solution for our problem.”
Oz, a heart surgeon, defended some recently revised federal vaccine recommendations as well as past comments from President Donald Trump and the nation’s health chief, Robert F. Kennedy Jr., about the efficacy of vaccines. From Oz, there was a clear message on the measles. “Not all illnesses are equally dangerous and not all people are equally susceptible to those illnesses,” he told CNN’s “State of the Union.” “But measles is one you should get your vaccine.”
An outbreak in South Carolina in the hundreds has surpassed the recorded case count in Texas’ 2025 outbreak, and there is also one on the Utah-Arizona border. Multiple other states have had confirmed cases this year. The outbreaks have mostly impacted children and have come as infectious disease experts warn that rising public distrust of vaccines generally may be contributing to the spread of a disease once declared eradicated by public health officials.
▶ Read more
Attorney General Pam Bondi, center, flanked by FBI Director Kash Patel, left, and Jeanine Pirro, U.S. Attorney for the District of Columbia, appears before reporters at the Justice Department, Friday, Feb. 6, 2026, in Washington, to announce the capture of a key participant in the 2012 attack on a U.S. compound that killed four Americans in Benghazi, Libya. (AP Photo/J. Scott Applewhite)
Bad Bunny performs during the halftime show of Super Bowl 60 between the Seattle Seahawks and New England Patriots in Santa Clara, Calif., Sunday, Feb. 8, 2026. (Carlos Avila Gonzalez/San Francisco Chronicle via AP)
President Donald Trump waves to the media as he walks on the South Lawn upon his arrival to the White House, Monday, Feb. 9, 2026, in Washington. (AP Photo/Jose Luis Magana)
